Prestige Biologics Co., Ltd. (KOSDAQ:334970)
1,166.00
-65.00 (-5.28%)
At close: Oct 28, 2026
| Market Cap | 90.66B -62.6% |
| Revenue (ttm) | 26.67B +112.8% |
| Net Income | -51.22B |
| EPS | -658.76 |
| Shares Out | 77.75M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 621,924 |
| Open | 1,274.00 |
| Previous Close | 1,231.00 |
| Day's Range | 1,073.00 - 1,274.00 |
| 52-Week Range | 1,073.00 - 3,850.00 |
| Beta | 0.44 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | n/a |